Sara Halmos
About Sara Halmos
Sara Halmos serves as the Associate Director and Global Head of Molecular Technologies at Alloy Therapeutics, Inc., where she has worked since 2022. She has extensive experience in molecular biology and antibody engineering, having held various roles at companies such as AVEO Oncology and Compass Therapeutics.
Current Role at Alloy Therapeutics
Sara Halmos serves as the Associate Director and Global Head of Molecular Technologies at Alloy Therapeutics, Inc., a position she has held since 2022. In this role, she oversees the molecular technologies division, contributing to the development and implementation of innovative strategies in antibody discovery and engineering. Her leadership is focused on advancing the company's capabilities in molecular biology.
Previous Experience in Biotechnology
Prior to her current role, Sara Halmos held various positions in the biotechnology sector. She worked at Alloy Therapeutics, Inc. as Head of Molecular Biology and Senior Scientist from 2020 to 2022. She also served as a Senior Scientist and Bispecific Platform Lead at Compass Therapeutics LLC from 2019 to 2020. Her experience includes roles at AVEO Oncology as an Associate Scientist in Antibody Engineering and at GnuBIO, Inc. as an Associate Scientist in Molecular Biology.
Educational Background
Sara Halmos earned her Bachelor of Arts degree in Molecular Biology from Connecticut College, where she studied from 1998 to 2002. She furthered her education by obtaining a Master of Science in Nutritional Biochemistry from Tufts University between 2004 and 2006. Additionally, she completed a Project Management Training Certificate through the Corporate Education Group at Duke University.
Research Experience
Sara Halmos began her career in research as a technician at Massachusetts General Hospital, where she worked from 2002 to 2006. This role provided her with foundational experience in laboratory techniques and research methodologies. Throughout her career, she has focused on antibody discovery and engineering, contributing to advancements in molecular biology.